APTIMETYX

Swiss trademark · 692538 · Word mark · In force

Register entry

Registration number
692538
Application number
55520/2016
Status
In force
Type
Word mark
Filed
May 4, 2016
Registered
Sep 12, 2016
Published
Sep 12, 2016
Protected until
May 4, 2036
Priority
05.11.2015 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von Krebs, Schmerzen, Infektionen, Entzündungen, Hormonstörungen, Knochenstörungen und psychischen Störungen; Analgetika; Hormone; Psychopharmaka; Antiinfektiva; Antiphlogistika; Anti-Krebs-Präparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 3, 2026

    Renewed

    Expiry date
    04.05.2026 → 04.05.2036

    Published in Swissreg on 03.02.2026

  2. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  3. Aug 14, 2019

    Licensee entered

    Exclusive licensee
    Ipsen Pharma SAS, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France

    Published in Swissreg on 14.08.2019

  4. Aug 13, 2019

    Holder’s address changed

    Owner
    Exelixis, Inc., 210 East Grand Avenue, South San Francisco, CA-94080, USA → Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, CA 94502, USA

    Published in Swissreg on 13.08.2019

  5. Sep 12, 2016

    Registered

    Published in Swissreg on 12.09.2016

Parties

Holder

Exelixis, Inc.

1851 Harbor Bay Parkway, Alameda, CA 94502, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Exclusive licensee

Ipsen Pharma SAS

65 Quai Georges Gorse, 92100 Boulogne-Billancourt, FR

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.